Biomarker-matched drug combos shrink treatment-resistant melanoma in preclinical models

Role of MCL1 in resistance to BCL2 inhibition. Credit: Nature Communications (2026). DOI: 10.1038/s41467-026-74691-9

A new study led by researchers…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *